Diagnostic Medical Systems SA
PAR:ALDMS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Diagnostic Medical Systems SA
Net Issuance of Common Stock
Diagnostic Medical Systems SA
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Diagnostic Medical Systems SA
PAR:ALDMS
|
Net Issuance of Common Stock
€6.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Edap Tms SA
NASDAQ:EDAP
|
Net Issuance of Common Stock
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Biomerieux SA
PAR:BIM
|
Net Issuance of Common Stock
-€18.2m
|
CAGR 3-Years
51%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-39%
|
|
|
S
|
SMAIO SA
PAR:ALSMA
|
Net Issuance of Common Stock
-€87.2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amplitude Surgical SA
PAR:AMPLI
|
Net Issuance of Common Stock
-€27k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mauna Kea Technologies SA
PAR:ALMKT
|
Net Issuance of Common Stock
€1.9m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-11%
|
|
Diagnostic Medical Systems SA
Glance View
Diagnostic Medical Systems engages in the development, design, and production of medical imaging systems. The company is headquartered in Mauguio, Occitanie and currently employs 123 full-time employees. The firm manufactures a range of products for bone densitometry examination, including the ultrasound imaging system UBIS 5000, Challenger Envision, Stratos dR and Stratos. In the radiology sector, its products include Baccara dRF 43, EOL, Platinum and Da Vinci solutions, among others. In addition, it offers such products as scanners, transcranial Doppler, and Giotto Image mammography system. The firm operates several direct subsidiaries, AXS Medical, Apelem SAS, which manufactures radiology equipment, Medilink SARL, which produces Doppler and bone densitometry devices, Apelem SA, based in Spain, Alpha MOS based in France and one indirect subsidiary, SA Apelem and one indirect affiliated company, Spectrap.
See Also
What is Diagnostic Medical Systems SA's Net Issuance of Common Stock?
Net Issuance of Common Stock
6.6m
EUR
Based on the financial report for Dec 31, 2025, Diagnostic Medical Systems SA's Net Issuance of Common Stock amounts to 6.6m EUR.
What is Diagnostic Medical Systems SA's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 3Y
4%
Over the last year, the Net Issuance of Common Stock growth was 59 845%. The average annual Net Issuance of Common Stock growth rates for Diagnostic Medical Systems SA have been 4% over the past three years .
